David McKinney leads medicinal chemistry and data science at the Broad Institutes Center for the Development of Therapeutics. He translates biological insights into new therapies, drawing on extensive experience in drug discovery, including high-throughput screening and lead optimization. He earned an MS from the University of Illinois and an MPH from Tufts University.
While at AstraZeneca, he coordinated an external chemistry team to deliver the first analog of the natural product Negamycin with improved whole-cell activity.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.